INGENIA THERAPEUTICS - Trademark Details
Status: 733 - Fourth Extension - Granted
Serial Number
88393561
Word Mark
INGENIA THERAPEUTICS
Status
733 - Fourth Extension - Granted
Status Date
2021-11-01
Filing Date
2019-04-19
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
021125, 260112, 260120, 260121, 260131 - Other parts of the human body. Circles with bars, bands and lines. Circles within a circle. Circles that are totally or partially shaded. Five or more circles.
Published for Opposition Date
2019-09-17
Attorney Name
Law Office Assigned Location Code
M20
Employee Name
WHITTAKER BROWN, TRACY
Statements
Indication of Colors claimed
The color(s) red, grey is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text
"THERAPEUTICS"
Description of Mark
The mark consists of a design featuring a circle containing blood vessels and five circles representing cells. The left half of the circle is grey and the right half is red, and the details and background of the mark are presented in negative space that will appear in the color of the surface upon which it is placed. The red stylized term "INGENIA" is presented to the right of the design over the grey stylized wording "THERAPEUTICS".
Goods and Services
Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for skin care; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Anti-diabetic pharmaceuticals; Antibacterial pharmaceuticals; Cardiovascular pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Ocular pharmaceuticals
Goods and Services
Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Development of pharmaceutical preparations and medicines; Research and development in the pharmaceutical and biotechnology fields
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2019-05-06
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2019-05-06
Primary Code
042
Current Trademark Owners
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Correspondences
Name
Jenevieve Maerker
Address
Please log in with your Justia account to see this address.
Trademark Events
| Event Date | Event Description |
| 2019-04-23 | NEW APPLICATION ENTERED IN TRAM |
| 2019-05-06 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2019-05-07 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| 2019-06-28 | ASSIGNED TO EXAMINER |
| 2019-07-01 | NON-FINAL ACTION WRITTEN |
| 2019-07-01 | NON-FINAL ACTION E-MAILED |
| 2019-07-01 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2019-08-01 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2019-08-08 | ASSIGNED TO LIE |
| 2019-08-13 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2019-08-13 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2019-08-14 | EXAMINERS AMENDMENT -WRITTEN |
| 2019-08-14 | EXAMINERS AMENDMENT E-MAILED |
| 2019-08-14 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 2019-08-14 | EXAMINER'S AMENDMENT ENTERED |
| 2019-08-14 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2019-08-28 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2019-09-17 | PUBLISHED FOR OPPOSITION |
| 2019-09-17 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2019-11-12 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 2020-03-06 | TEAS EXTENSION RECEIVED |
| 2020-03-06 | EXTENSION 1 FILED |
| 2020-03-06 | EXTENSION 1 GRANTED |
| 2020-03-10 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2020-10-30 | TEAS EXTENSION RECEIVED |
| 2020-10-30 | EXTENSION 2 FILED |
| 2020-10-30 | EXTENSION 2 GRANTED |
| 2020-11-03 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2021-04-28 | TEAS EXTENSION RECEIVED |
| 2021-04-28 | EXTENSION 3 FILED |
| 2021-04-28 | EXTENSION 3 GRANTED |
| 2021-04-30 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2021-11-01 | TEAS EXTENSION RECEIVED |
| 2021-11-01 | EXTENSION 4 FILED |
| 2021-11-01 | EXTENSION 4 GRANTED |
| 2021-11-03 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
